Clinical Trials Browser

Phase 1 × Rectal Neoplasms × bavituximab × Clear all

NCT01634685 2020-08-20

A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma

Phase 1 Completed

Gastrointestinal

Rectal Neoplasms